傲农生物(603363) - 2025 Q2 - 季度业绩预告(更正)

Current Period Performance Forecast The company forecasts a turnaround to profitability in H1 2025, with net profit attributable to shareholders between 320 million CNY and 400 million CNY, though non-recurring adjusted net profit is expected to remain a loss Performance Forecast (CNY) | Metric | Forecasted Amount (CNY) | | :--- | :--- | | Performance Forecast Period | January 1, 2025 to June 30, 2025 | | Net Profit Attributable to Shareholders | 320.00 million CNY to 400.00 million CNY | | Net Profit Attributable to Shareholders After Non-Recurring Items | -20.00 million CNY to -30.00 million CNY | - This performance forecast indicates a turnaround to net profit profitability[5] - These forecasted figures are preliminary calculations by the company's finance department and have not been audited by a certified public accountant[7][12] Prior Period Performance Comparison The company's performance significantly improved compared to the prior year, with 2025 H1 projected to achieve a substantial turnaround from 2024 H1 losses of -540 million CNY net profit and -604 million CNY non-recurring adjusted net profit Performance Comparison (million CNY) | Metric | 2025 H1 (Forecast) | 2024 H1 (Prior Period) | | :--- | :--- | :--- | | Net Profit Attributable to Shareholders (million CNY) | 320.00 to 400.00 | -540.01 | | Non-Recurring Adjusted Net Profit Attributable to Shareholders (million CNY) | -20.00 to -30.00 | -603.60 | | Earnings Per Share (CNY) | Not Applicable | -0.62 | Analysis of Performance Turnaround Factors The company's turnaround is primarily driven by bankruptcy reorganization benefits, including asset divestment, debt reduction, and interest expense savings, alongside core business recovery, optimized production, and recognized reorganization gains, though H1 non-recurring adjusted net profit remains negative due to depreciation from facilities awaiting resumption - Through bankruptcy reorganization, the company divested most idle assets, significantly reduced debt size and interest expenses, and alleviated operational burdens[10] - Key businesses such as hog farming, feed, and slaughtering have recovered and been reshaped, with retained large-scale hog farms resuming operations orderly, sow inventory rapidly recovering, production performance significantly improving, and raw material costs reduced through strategic procurement[10] - During the reporting period, the company recognized reorganization gains as creditors continued to receive debt repayment resources[11] - The negative non-recurring adjusted net profit for the first half is primarily due to approximately 50 million CNY in reduced profit from depreciation and amortization of hog farms and feed mills awaiting resumption[11] Risk Warning and Other Notes The company highlights that this performance forecast is an unaudited preliminary calculation, with final accurate financial data subject to the officially disclosed 2025 semi-annual report, advising investors to consider investment risks - These performance forecast figures are preliminary calculations made by the company's finance department based on its professional judgment and have not been audited by a certified public accountant[12] - The final accurate financial data will be subject to the company's officially disclosed 2025 semi-annual report; investors are advised to exercise caution regarding investment risks[13]